Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Smerud Medical Research International AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7592
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinical trial management, project funding, consulting, data management and training services. Smerud Medical provides clinical trial management such as planning of clinical development programmes, feasibility studies and closing of trial centres, among others. The company provides project funding services such as research grants, and project strategy. It also provides consulting services such as clinical development programmes, regulatory strategy and ethics, among others. The company operates through its offices located in Sweden, Denmark, Norway, Finland, Poland, Russia, the UK, and others. Smerud Medical is headquartered in Oslo, Norway.

Smerud Medical Research International AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Smerud Medical Research International AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Smerud Medical Research International AS, Medical Devices Deals, 2012 to YTD 2018 10
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Bionor Enters into Agreement with Smerud Medical Research International 12
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 13
OptiNose US Enters Into Collaboration with Oslo University Hospital, SINTEF and Smerud Medical Research International 14
Smerud Medical Research International AS – Key Competitors 15
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Key Facts 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Smerud Medical Research International AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Smerud Medical Research International AS, Deals By Therapy Area, 2012 to YTD 2018 8
Smerud Medical Research International AS, Medical Devices Deals, 2012 to YTD 2018 10
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bionor Enters into Agreement with Smerud Medical Research International 12
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 13
OptiNose US Enters Into Collaboration with Oslo University Hospital, SINTEF and Smerud Medical Research International 14
Smerud Medical Research International AS, Key Competitors 15
Smerud Medical Research International AS, Subsidiaries 16

List of Figures
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Smerud Medical Research International AS, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Basic Energy Services Inc (BAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Basic Energy Services Inc (Basic Energy) is an oil and gas company that offers well site services. The company’s services including well servicing, snubbing, water logistics, saltwater disposal, pumping services, coil tubing, water solutions, wireline, contract drilling, coil tubing and tubu …
  • Ahimsa Industries Limited:戦略・SWOT・企業財務分析
    Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Erin Energy Corp (ERINQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Erin Energy Corp (Erin Energy), formerly CAMAC Energy Inc, a subsidiary of CAMAC Energy Holdings Ltd, is an oil and gas company that develops and produces oil and gas assets. The company's portfolio includes seven licenses in four countries and covers an area of approximately 19,000 sq km of …
  • Versantis AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also …
  • Bega Cheese Ltd:企業のM&A・事業提携・投資動向
    Bega Cheese Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bega Cheese Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Fujitsu Limited (6702):企業の財務・戦略的SWOT分析
    Fujitsu Limited (6702) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Medtecs International Corp Ltd (546):企業の財務・戦略的SWOT分析
    Summary Medtecs International Corporation Ltd (Medtecs) is a medical device company that manufactures and distributes work wear apparels and medical device and consumables. The company's products include medical devices, healthcare textile work wear and hospitality textiles, among others. It also pr …
  • East African Breweries Limited:企業の戦略・SWOT・財務情報
    East African Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary East African Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Balfour Beatty plc:企業の戦略・SWOT・財務分析
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • Isrotel Hotels Management Inc.
    Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Oil States International Inc (OIS):企業の財務・戦略的SWOT分析
    Oil States International Inc (OIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • The National Commercial Bank:企業の戦略・SWOT・財務情報
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Rice University-製薬・医療分野:企業M&A・提携分析
    Summary Rice University is an educational service provider that provides graduate and undergraduate education programs and research services. The institute offers academic programs in the field of applied physics, cognitive sciences, computational science and engineering, environment, leadership, mi …
  • Vale Canada Ltd:企業の戦略・SWOT・財務情報
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NCC AB:戦略・SWOT・企業財務分析
    NCC AB - Strategy, SWOT and Corporate Finance Report Summary NCC AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆